899
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Efficacy of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

, , , &
Pages 230-233 | Received 06 Dec 2005, Published online: 08 Jul 2009

Figures & data

Table I.  Best response after 3 and 6 cycles of pegylated liposomal doxyrubicin in patients with aHCC

Figure 1.  The overall survival (OS) and progression free survival (PFS) curves for patients with aHCC treated with pegylated liposomal doxorubicin.

Figure 1.  The overall survival (OS) and progression free survival (PFS) curves for patients with aHCC treated with pegylated liposomal doxorubicin.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.